July 2026 - Multibillion-dollar trading event anticipated as major indices undergo quarterly and semi-annual reviews.
ReNerve (ASX: RNV) is advancing its transition to a commercial medical device company, with CEO Dr Julien Chick highlighting ...
July 2026 - Portfolio manager Nick Kelly discusses WMA's strategy to bridge discount and navigate alternative asset market dynamics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results